Minor effect of tolcapone a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: A microdialysis study in anaesthetized rats

Pharmacology and Toxicology

Volumn 78, Issue 6, 1996, Pages 392-396

  Tuomainen, Päivi ^a   Törnwall, Martti ^a   Männistö, Pekka T ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; HOMOVANILLIC ACID; OR 1404; PARGYLINE; TOLCAPONE; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029943947     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00224.x     Document Type: Article

References (39)

1. Acquas, E., E. Carboni, R. H. A. Deree, M. Da Prada & G. Di Chiara: Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J Neurochem. 1992, 59, 326-330.
2. Arbuthnott, G. W., I. S. Fairbrother & S. P. Butcher: Dopamine release and metabolism in the rat strialum: An analysis by in vivo brain dialysis. Pharmacol. Therap. 1990, 48, 281-293.
3. Borgulya, J., H. Bruderer, K. Bernauer, G. Zürcher & M. Da Prada: Catechol-O-methyltransferase-inhibiting pyrocatechol derivalives synthesis and structure-activity studies. Helv. Chim. Acta 1989, 72, 952-968.
4. Buu, N. T.: Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors. Biochem. Pharmacol. 1989, 38, 1685-1692.
5. Buu, N. T. & M. Angers: Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain. Biochem. Pharmacol. 1987, 36, 1731-1735.
6. Bäckström, R., E. Honkanen, A. Pippuri, P. Kairisalo, J. Pystynen, K. Heinola, E. Nissinen, I.-B. Lindén, P. T. Männistö, S. Kaakkola & P. Pohto: Synthesis of some novel potent and selective catechol-O-methyltransferase inhibitors. J. Med. Chem. 1989, 32, 841-846.
7. Carboni, E., A. Imperato, L. Perezzuni & G. Di Ghiara: Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 1989, 28, 653-661.
8. Carruba, M. O., G. Bondiolotti, G. B. Picotti, N. Catteruccia & M. Da Prada: Effects of diethyl ether, halotane, ketamine and urethane on sympathetic activity in the rat. Eur. J. Pharmacol. 1987, 134, 15-24.
9. Da Prada, M., H. H. Keller, L. Pieri, R. Kettler & W. E. Haefely: The pharmacology of Parkinson's disease: basic aspects and recent advances. Experientia 1984, 40, 1165-1172.
10. Etemadzadeh, E., L. Koskinen & S. Kaakkola: Computerized rotometer apparatus for recording circling behavior. Meth. Find. Exp. Clin. Pharmacol. 1989, 11, 399-407.
11. Fahn, S.: 'On-off' phenomenon with levodopa therapy in parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology 1974, 24, 431-441.
12. Hardie, R. J., S. L. Malcolm, A. J. Lees, G. M. Stern & J. G. Allen: The pharmacokinetics of intravenous and oral levocopa in patients with Parkinsons disease who exhibit on-off fluctuations. Brit. J. Clin. Pharmacol 1986, 22, 429-436.
13. Kaakkola, S. & R. J. Wurtman: Effects of COMT inhibitors on striatal dopamine metabolism: a mierodialysis study. Brain Res. 1992, 587, 241-249.
14. Kaakkola, S. & R. J. Wurtman: Effects of COMT inhibitors and L-dopa with and without carbidopa on extracellular dopamine in the rat striatum. J. Neurochem. 1993, 60, 137-144.
15. Karoum, F., S. J. Chrapusta, R. Brinjak, A. Hitri & R. J. Wyatt: Regional effect of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamic of dopamine release and metabolism in rat brain. Brit. J. Phrmacol. 1994, 113, 1391-1399.
16. Kopin, I.: Catecholamine metabolism: basic aspects and clinical significance. Pharmacol. Rev. 1985, 37, 333-364.
17. Kuruma, I., G. Bartholini, R. Tissot & A. Pletscher: Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. J. Pharm. Pharmacol. 1972, 24, 289-294.
18. Maggi, C. A. & A. Meli: Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part I: General considerations. Experientia 1986, 42, 109-114.
19. Maj, J., Z. Rogóz, G. Skuza, H. Sowinska & J. Superata: Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease. J. Neural Transm. [P-D Sect.] 1990, 2, 101-112.
20. Messiha, F. S., T. H. Hsu & J. R. Bianchine: Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. J. Clin. Invest. 1972, 51, 452-455.
21. Männistö, P. T. & P. Tuomainen: Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat. Naunyn-Schmiedebergs Arch. Pharmacol. 1991, 344, 412-418.
22. Männistö, P. T., I. Ulmanen, K. Lundström, J. Taskinon, J. Tenhunen, C. Tilgmann & S. Kaakkola: Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors. Prog. Drug Res. 1992, 39, 291-350.
23. Männistö, P. T, I, Ulmanen, J. Taskinen & S. Kaakkola: Catechol O-methyltransferase (COMT) and COMT inhibitors. In: Design of enzyme inhibitors as drugs. Ed.: M. Sandler & H. J. Smith. Oxford University Press, Oxford, 1994, pp. 625-647.
24. Nissbrandt, H. & A. Carlsson: Turnover of dopamine and dopamine metabolites in rat brain: Comparison between striatum and substantia nigra. J. Neuroehem. 1987, 49, 959-965.
25. Parker, E. M. & L. X. Cubeddu: Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J. Pharmacol. Exp. Therap. 1988, 245, 199-210.
26. Parry, T. J., T. L. Carter & J. G. Mcelligott: Physical and chemical considerations in the in vitro calibration of microdialysis probes for biogenic amme neurotransmitters and metabolites. J. Neurosci. Methods 1990, 32, 175-183.
27. Paxinos, G. & C. Watson: The rat brain in stereotaxic coordinates. Academic Press, New York, 1986.
28. Reilly, D. K., L. Rivera-Calimlim & D. Van Dyke: Catechol-O-methyltransferase activity: a determinant of levodopa response. Clin. Pharmaeol. Therap. 1980, 28, 278-286.
29. Rivera-Calimlim, L., D. Tandon, F. Anderson & R. Joynt. The clinical picture and plasma levodopa metabolite profile of Parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor. Arch. Neurol. 1977, 34, 228-232.
30. Smythe G. A., R. M. Gleeson & B. H. Stead. Stimulation of the hypothalamic-pituitary-adrenal axis and inhibition of growth hormone release via increased central noradrenaline neuronal activity by urethane anaesthesia in the rat: blockade by clonidine. Aust. J. Biol Sci. 1987, 40, 91-96.
31. Suaudchagny, M. F., P. Brun, M. Buda & F. Ganon: Fast in vivo monitoring of electrically evoked dopamine release by differential pulse amperometry with untreated carbon fibre electrodes. J. Neurosci. Methods 1992,45, 183-190.
32. Tallarida, R. J. & R. B. Murray: Manual of pharmacological calculations with computcr programs. Springer-Verlag, New York, Berlin, Heidelberg, London, Paris, Tokyo, 1987.
33. Tepper, J. M., I. Creese & D. H. Schwartz: Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis. Brain Res. 1991, 559, 283-292.
34. Törnwall, M. & P. T. Männistö: Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats. Eur. J. Pharmacol. 1993, 250, 77-84.
35. Törnwall, M., P. Tuomainen & P. T. Männistö: Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase. Eur. J. Pharmacol 1993, 239, 39-45.
36. Tornwall, M., S. Kaakkola, P. Tuomainen, A. Kask & P. T. Männistö: Comparison of two new inhibitors of catechol O-methyltransferase on striatal dopamine metabolism: a microdialysis study in rats. Brit. J. Pharmacol. 1994, 112, 13-18.
37. Ungerstedt, U. & G. W. Arbuthnott: Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970, 24, 485-493.
38. Warenycia, M. W. & G. M. McKenzie: Responses of striatal neurons to anesthetics and analgetics in freely moving rats. Gen. Pharmacol. 1984, 15, 517-522.
39. Warenycia, M. W. & G. M. McKenzie: Excitation of striatal neurons by dexamphetamine is not abolished by either chloral hydrate or urethane anaesthesia. Neuropharmacology 1988, 27, 1309-1312.